Showing results (131-140 of 263) with videos related to

Sort By:
Pageof 27
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 21, 2006
[Clinical usefulness of the (1-->3)-beta-D-glucan measurement kit using the improved alkaline pretreatment method--comparison with conventional method]Koichiro Yoshida, Naoyuki Miyashita, Yasushi Obase, et al.
Cell|March 10, 2004
A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressorsYiwen Jan, Michelle Matter, Jih-tung Pai, et al.
Molecular and Cellular Neurosciences|October 16, 2004
Migrating and myelinating potential of neural precursors engineered to overexpress PSA-NCAMIsabelle Franceschini, Sandrine Vitry, Françoise Padilla, et al.
Molecular Cancer Therapeutics|November 16, 2004
The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cellsSeiji Doi, Hiroshi Soda, Mikio Oka, et al.
Cancer Science|January 31, 2006
Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancerSatoshi Ishizone, Kazuyoshi Yamauchi, Shigeyuki Kawa, et al.
Biochemical and Biophysical Research Communications|May 11, 2005
An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancerLizhong Wang, Junya Mitoma, Norihiko Tsuchiya, et al.
Glycobiology|May 6, 2005
Polysialic acid facilitates tumor invasion by glioma cellsMasami Suzuki, Misa Suzuki, Jun Nakayama, et al.
Nature Communications|January 17, 2013
hVps41 and VAMP7 function in direct TGN to late endosome transport of lysosomal membrane proteinsMaaike S Pols, Eline van Meel, Viola Oorschot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibodyYoshihiro Ohue, Koji Kurose, Yu Mizote, et al.
Oncotargets and Therapy|July 20, 2017
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunctionMidori Shimada, Minoru Fukuda, Masaaki Fukuda, et al.
Pageof 27